Quest Diagnostics announces final results of its cash tender offer

Reviewed

From Quest DiagnosticsNov 20 2009

Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes"). Additional terms and conditions of the Tender Offer are set forth in the offer to purchase dated November 12, 2009 and the related letter of transmittal. The settlement date for the Tender Offer will be today, November 20, 2009.

Source:

Quest Diagnostics Incorporated

Posted in:

Tags: Diagnostic, Diagnostics

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Quest Diagnostics. (2019, June 20). Quest Diagnostics announces final results of its cash tender offer. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20091120/Quest-Diagnostics-announces-final-results-of-its-cash-tender-offer.aspx.
MLA
Quest Diagnostics. "Quest Diagnostics announces final results of its cash tender offer". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20091120/Quest-Diagnostics-announces-final-results-of-its-cash-tender-offer.aspx>.
Chicago
Quest Diagnostics. "Quest Diagnostics announces final results of its cash tender offer". News-Medical. https://www.news-medical.net/news/20091120/Quest-Diagnostics-announces-final-results-of-its-cash-tender-offer.aspx. (accessed November 21, 2024).
Harvard
Quest Diagnostics. 2019. Quest Diagnostics announces final results of its cash tender offer. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20091120/Quest-Diagnostics-announces-final-results-of-its-cash-tender-offer.aspx.